Related Experiment Video
Updated: Aug 23, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Post-COVID-19 Cholangiopathy: A Systematic Review
Beshoy Yanny1, Mohammed Alkhero2, Mohammed Alani2
1University of California, Los Angeles, Los Angeles, CA, USA.
Post-COVID-19 cholangiopathy (PCC) is a severe complication of COVID-19. This study investigated 30 cases, revealing significant liver enzyme elevations and the need for further research into its pathophysiology and treatment.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- Post-COVID-19 cholangiopathy (PCC) is a rare, severe complication of SARS-CoV-2 infection.
- The epidemiology, pathogenesis, and clinical course of PCC remain poorly understood.
Purpose of the Study:
- To elucidate the characteristics of Post-COVID-19 cholangiopathy.
- To understand the epidemiology, mechanism of action, histology, imaging findings, and outcomes of PCC.
Main Methods:
- A systematic literature search was conducted across PubMed, Cochrane Library, Embase, and Web of Science from December 2019 to December 2021.
- Data extraction focused on epidemiological factors, mechanisms, histology, imaging, and patient outcomes.
Main Results:
- Thirty cases of PCC were identified, predominantly affecting men (83.3%) with a mean age of 53.7 years.
- All affected patients required intensive care and mechanical ventilation, with a mean of 63.5 days from COVID-19 infection to severe liver disease.
- Significant elevations in liver enzymes (alkaline phosphatase, AST, ALT) and bilirubin were observed; four patients underwent liver transplantation.
Conclusions:
- Post-COVID-19 cholangiopathy is a serious and progressive condition following COVID-19 infection.
- Further research is crucial to understand PCC pathophysiology and optimal management strategies.
- Clinicians should maintain a high index of suspicion for PCC in patients presenting with cholestatic liver injury post-COVID-19.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

